Precision Health Reports Announces Improved Lipoprotein Management Goals in their Cardiometabolic Risk Assessment
Newly harmonized guidelines implemented into the personalized assessments further the shared decision-making and risk reduction strategies to reduce individual disease risk.
Newly harmonized guidelines implemented into the personalized assessments further the shared decision-making and risk reduction strategies to reduce individual disease risk.
LITTLE ROCK, AR – August 8, 2023 – Precision Health Reports, a pioneer in cutting-edge health cardiometabolic risk assessment solutions, is thrilled to announce the release of a significant enhancement to its renowned Cardiometabolic Risk Assessment product. This latest update reflects the emerging harmonization between prominent guidelines and recommendations from key medical associations, including the American College of Cardiology (ACC), the European Society of Cardiology (ESC), and the Diabetes Care and Research in Metabolism (DCRM).
The key part of this product enhancement lies in the presentation of "threshold goals," for atherogenic lipid/lipoprotein values to reflect this harmonized guideline approach for individual management of heart attack and stroke risk. Designed to reflect the minimally acceptable reduction in these biomarkers that are necessary for risk reduction in specific risk groups, these threshold goals reflect a clearer approach toward personalized health optimization.
"Precision Health Reports is dedicated to empowering individuals to take control of their health journey through informed decision-making," said Dr. William Cromwell, Chief Medical Officer at Precision Health Reports. " Our updated Cardiometabolic Risk Assessment leverages the latest insights from expert guidelines to give healthcare providers and patients comprehensive insight into individual cardiometabolic risk and specific individual goals. This improves the shared decision-making conversation between patients and their physicians to develop strategies to reduce cardiometabolic risk."
The core of the Assessment update revolves around determining the proper reduction for atherogenic lipids/lipoproteins that are tailored to an individual's risk group. This strategy is rooted in the understanding that sustained reductions in ApoB levels contribute significantly to risk mitigation. As a result, individuals are encouraged to maintain values well below the threshold goal for their respective risk group.
"At Precision Health Reports, we believe that early, personalized risk identification and intervention is a valuable tool in extending healthspan," said Matt Martin, CEO of Precision Health Reports. "Our enhanced Cardiometabolic Risk Assessment product is a testament to our commitment to a guideline-centric design, as we empower shared decision-making."
This groundbreaking update to the Cardiometabolic Risk Assessment product reinforces Precision Health Reports' commitment to powering clinical shared decision-making, driving meaningful change in personalized health management and risk reduction strategies.
Learn more about our harmonized lipoprotein management goals at: https://precisionhealthreports.com/harmonized-lipoprotein-management-goals.
About Precision Health Reports
Precision Health Reports is a digital health services company focused on powering shared decision-making for individual cardiometabolic disease risk. Co-founded by Matt Martin and renowned lipidologist William Cromwell, MD in April 2020, Precision Health Reports delivers a comprehensive personalized assessment report to primary care providers that uniquely integrates the complex guidelines for comprehensive and precision risk identification for each of their patients. To learn more about Precision Health Reports, visit https://precisionhealthreports.com or find us on Facebook, Instagram, Twitter, or LinkedIn.
###
Precision Health Reports contact:
Matthew Martin, 919.601.5005 or hello@precisionhealthreports.com
Precision Health Reports Announces Integration with Curative Health Insurance Company for New Member Benefits
Precision Health Reports’s integration with Curative Health Insurance Company powers early individualized cardiometabolic risk detection for Curative’s insured members.
LITTLE ROCK, AR – March 21, 2023 – Curative Inc., a leading health services company that recently launched a new health plan in Texas, has partnered with Precision Health Reports, Inc. to provide its members with a unique cardiometabolic risk evaluation. Curative members who are pre-screened at their Baseline Visit as being at high risk for a cardiometabolic disease have the option of being further evaluated using an advanced Cardiometabolic Risk Assessment from Precision Health Reports.
“We are excited to incorporate this comprehensive personalized diagnostic tool into our Baseline Visit to better enable shared decision-making with our members,” said Fred Turner, CEO and co-founder of Curative. “Accurately identifying individuals at risk for cardiometabolic disease, and then supporting them with our in-house physicians and care navigators is critical to supporting healthy individual outcomes and reducing employers’ overall healthcare spend.”
The Precision Health Reports’Cardiometabolic Risk Assessment is a comprehensive diagnostic tool launched in 2021 to efficiently harmonize the multiple accepted guidelines to identify individual risk for developing metabolic syndrome, type 2 diabetes, or atherosclerotic cardiovascular disease (ASCVD) events such as a stroke or heart attack. The Risk Assessment integrates relevant medical history with the most outcome-proven biomarkers in a format that helps the patient understand their risk and participate in shared decision-making about the next steps.
“Powering evidence-based shared decision-making between healthcare providers and their patients to find individual cardiometabolic disease risk is vital to early preventative care,” said Matthew Martin, co-founder and CEO of Precision Health Reports. “Cardiovascular disease remains the #1 leading cause of death in the US with treatment costing upwards of $400 billion annually. Our assessment is built to simplify the complex integration data and proven guidelines that enable healthcare providers and patients the time to focus on the best risk reduction interventions. These early mostly dietary and lifestyle primary interventions lead to healthier outcomes and lower the instances of costly secondary disease care.”
The Curative insurance plan is available to employers across Texas with a high-quality network of providers including primary and specialty care, telemedicine, urgent care, prescribed pharmaceuticals, wellness and preventative care, mental and behavioral health care, and leading hospital facilities. To learn more about Curative’s new healthcare plan, visit https://curative.com.
*To qualify, members need to complete a Baseline Visit within 120 days of the plan's effective date, which kicks off support of the member’s well-being through every step of their health journey.
###
About Curative
Curative is a leading health care services company that has created and launched a first-of-its-kind employer-based health insurance plan. Co-founded by CEO Fred Turner and CTO Isaac Turner (no relation) in 2020, Curative is reengineering health insurance by providing unmatched simplicity and cost transparency with a competitive monthly premium and zero additional costs*. Curative is remaking our healthcare system into one that works for and supports members’ whole health and well-being through every step of their personal health journey. Previously, Curative and its managed medical entities were national leaders bringing COVID-19 testing and vaccine-administration resources to bear in response to the pandemic. For more information on Curative, visit https://curative.com, or follow us on Facebook, Instagram, Twitter, or LinkedIn.
About Precision Health Reports
Precision Health Reports is a digital health services company focused on powering shared decision-making for individual cardiometabolic disease risk. Co-founded by Matt Martin and renowned lipidologist William Cromwell, MD in April 2020, Precision Health Reports delivers a comprehensive personalized assessment report to primary care providers that uniquely integrates the complex guidelines for comprehensive and precision risk identification for each of their patients. To learn more about Precision Health Reports, visit https://precisionhealthreports.com or find us on Facebook, Instagram, Twitter, or LinkedIn.
Precision Health Reports Launches New Product to Evaluate Cardiometabolic Disease Risk
Raleigh-based company delivers a new tool for medical professionals to more easily evaluate individual patient risk for developing type 2 diabetes, heart attack, or stroke.
[RALEIGH, NC, March 17] Precision Health Reports, a digital health diagnostics company, launched its new comprehensive and actionable Cardiometabolic Risk Assessment to enable healthcare providers and patients to assess and manage heart attack, stroke, and diabetes risk more efficiently.
“Cardiometabolic disease is complicated to assess and manage. In addition to a patient’s medical history and physical exam, providers have to integrate various biomarkers and multiple national and international guidelines to determine a person’s unique cardiometabolic risk,” said Dr. William Cromwell, M.D., Chief Medical Officer for Precision Health Reports. “Most physicians simply do not have the time or the tools to integrate all these components to produce a comprehensive, actionable report that reflects a person’s cardiometabolic condition. We solve that problem for them by providing a comprehensive report that enables providers to formulate a treatment plan tailored to that patient.”
Cardiovascular disease is the #1 leading cause of death in the U.S. with type 2 diabetes being the 7th leading cause of death. Together, these two devastating diseases make up overall cardiometabolic disease. Catching disease progression early can prevent more than $10,000 per patient per year in direct healthcare costs. This disease costs over $500B in direct healthcare costs annually with that total growing year over year.
“We all know someone who has experienced a debilitating heart attack or stroke or even struggles with daily management of type 2 diabetes,” explains Matthew Martin, CEO of Precision Health Reports. “With increased awareness of the second-order effects of diabetes and cardiovascular disease because of the relationship with the COVID-19 pandemic, we are confident that we can assist millions with understanding their risk and regaining control of their personal health.”
Precision Health Reports integrates personal medical information, physical findings, outcome-proven biomarkers, and evidence-based guidelines to produce comprehensive individual reports that uniquely discriminate a person’s risk for cardiometabolic diseases. Healthcare providers using these risk assessments can tailor individual therapy plans to reduce a person’s risks of diabetes, and cardiovascular events then track the individual’s response to their prescribed treatment plan.
Precision Health Reports was founded in April 2020 to provide a digital health diagnostics tool that address individual cardiometabolic risk. Learn more at https://precisionhealthreports.com.
###
If you would like more information about this announcement, please call Matthew Martin at 919.601.5005 or email at hello@precisionhealthreports.com.
Precision Health Reports announced as one of twelve finalist in the NC IDEAS Fall 2020 SEED Grant Cycle
DURHAM, NC – October 26, 2020 – NC IDEA, a private foundation committed to supporting entrepreneurial ambition and economic empowerment in North Carolina, announced today that Precision Health Reports, Inc. is among the twelve finalist for their 30th cycle of the $50,000 NC IDEA SEED grant.
“To be selected in final twelve of over 130 applicants is a real honor,” stated Matthew Martin, CEO of Precision Health Reports. “We know that diabetic, metabolic, and cardiovascular disease is a real epidemic in our society and this selection furthers our opportunity to help healthcare providers across North Carolina and the United States identify patients’ risks earlier to intervene before the point of no return or a catastrophic health event.”
Over 34 million Americans suffer from type 2 diabetes and another 95 million Americans are pre-diabetic at risk of progressing into this disease that has an annual direct cost of $237 billion to the healthcare system. Similarly, cardiovascular disease affects 18.2 million Americans at a direct healthcare cost of over $318 billion annually and is the #1 leading cause of death. Early detection of these related cardiometabolic diseases is critical in preventing disease progression. Precision Health Reports makes identifying the risks associated with these diseases quick, easy, and accurate for their clients.
The company recently launched their Diabetic Risk Assessment with multiple healthcare providers across the country and will soon release their full Cardiometabolic Risk Assessment later this year. “With limited time to spend with each patient, doctors just do not have the time available to compile all of the biomarkers, individual risk factors, varying calculators, and guidelines,” said Dr. William Cromwell, Chief Medical Officer. “Our risk assessments arm healthcare providers with a proven tool to spend their limited clinical intervention time having a conversation with their patient about a plan of action to have a healthy outcome.”
For healthcare providers wishing to learn more about easily getting signed up to offer these risk assessments to your own patients, drop us a line at hello@precisionhealthreports.com. We look forward to helping you save lives and increase the healthspan of your patients!
Read the NC IDEA FOUNDATION Press Release
About NC IDEA FOUNDATION
NC IDEA is an independent private foundation committed to empowering North Carolinians to achieve their entrepreneurial potential. Through our powerful combination of competitive grants and programs, and a network of strategic partners, we help entrepreneurs when they need it most. NC IDEA’s resources are highly competitive, enabling the foundation to support North Carolina’s most ambitious entrepreneurs. We believe entrepreneurs transform communities and view our work as a catalyst for positive change. Learn more at www.ncidea.org.
About Precision Health Reports, Inc.
Precision Health Reports was founded in April 2020 to provide a digital health diagnostics tool that address individual cardiometabolic risk. Our mission is to give healthcare providers tools that allow them to address individual risks earlier in the disease cycle and enable them to prevent the progression to costly and deadly diabetes, heart attack, or stroke.
For media inquiries, please contact media@precisionhealthreports.com.
Precision Health Reports Announced as a Semi-Finalist in the NC IDEAS Fall 2020 SEED Grant Cycle
Precision Health Reports was among the 23 semi-finalist selectees selected from 131 submissions for the NC IDEA Foundation Fall 2020 SEED Grant Cycle.
Semi-Finalists Seeking $50,000 Each in NC IDEA’s 30th SEED Grant Cycle
DURHAM, NC – September 28, 2020 – NC IDEA, a private foundation committed to supporting entrepreneurial ambition and economic empowerment in North Carolina, announced today that the organization has selected 23 semi-finalists from across the state in its 30th SEED grant cycle. These semi-finalists were chosen from 131 competitive applications received by the organization.
“Even thirty cycles in, it’s still a difficult task narrowing down a competitive field of demographically and geographically diverse applicants,” said Thom Ruhe, President and CEO of NC IDEA. “We look forward to learning more about the group moving forward in the next phase of the process.”
The 23 Fall 2020 NC IDEA SEED Semi-Finalists include:
Ascend – Charlotte, NC
AuthorLoyalty – Waxhaw, NC
Blue Recruit, Inc – Raleigh, NC
Bundle – Charlotte, NC
Davos Corporation – Durham, NC
Dendi – Raleigh, NC
Double 20 Games – Raleigh, NC
FastQSR, LLC – Warrenton, NC
Growga – Chapel Hill, NC
Hush Buddy – Raleigh, NC
NanoVest Platform – Durham, NC
Newsco Inc. – Raleigh, NC
Point Motion – Winston-Salem, NC
Precision Health Reports, Inc – Raleigh, NC
PureSkill.gg – Mooresville, NC
Rosey Bloom’s, LLC – Winston-Salem, NC
Rownd – Durham, NC
Six Wing Studios – Raleigh, NC
Socialize – Raleigh, NC
Third Floor Technology – Cary, NC
Vizma Life Sciences – Durham, NC
Wrangle – Durham, NC
Yonitox Feminine Care Co. – Charlotte, NC
The semi-finalists have been invited to submit a full proposal with greater details by early October. Finalists will then be selected to present before a review panel comprised of experienced investors, industry experts and entrepreneurs. Grant recipients will be announced in mid-November. The $50,000 grants are intended to support business activities that validate target markets, reduce risk associated with early stage companies and help companies get to the point of suitability for growth; whether through investment or revenue.
About NC IDEA FOUNDATION: NC IDEA is an independent private foundation committed to empowering North Carolinians to achieve their entrepreneurial potential. Through our powerful combination of competitive grants and programs, and a network of strategic partners, we help entrepreneurs when they need it most. NC IDEA’s resources are highly competitive, enabling the foundation to support North Carolina’s most ambitious entrepreneurs. We believe entrepreneurs transform communities and view our work as a catalyst for positive change. Learn more at www.ncidea.org.
About Precision Health Reports, Inc: Precision Health Reports was founded in April 2020 to provide a digital health diagnostics tool that address individual cardiometabolic risk. Our mission is to give healthcare providers tools that allow them to address individual risks earlier in the disease cycle and enable them to prevent the progression to costly and deadly diabetes, heart attack, or stroke.